Kinase cascades and ligand-directed signaling at the kappa opioid receptor | SpringerLink
κ-opioid receptor - Wikipedia
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
Z0710N Human Kappa Opioid Receptor (OPRK1) | Montana Molecular
Scientists Take a Big Step toward Building a Better Opioid | Newsroom
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development – Maine Suboxone Treatment
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Neurophysiological process - Kappa-type opioid receptor in transmission of nerve impulses Pathway Map - PrimePCR | Life Science | Bio-Rad
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Study targets kappa opioid receptor to develop more effective drugs for pain management | Anesthesiology | Washington University School of Medicine in St. Louis
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications